SV2011003811A - Nuevos derivados de imidazo[1,2-a] pirimidina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met - Google Patents
Nuevos derivados de imidazo[1,2-a] pirimidina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de metInfo
- Publication number
- SV2011003811A SV2011003811A SV2011003811A SV2011003811A SV2011003811A SV 2011003811 A SV2011003811 A SV 2011003811A SV 2011003811 A SV2011003811 A SV 2011003811A SV 2011003811 A SV2011003811 A SV 2011003811A SV 2011003811 A SV2011003811 A SV 2011003811A
- Authority
- SV
- El Salvador
- Prior art keywords
- new
- pyrimidine
- medicines
- pharmaceutical compositions
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
LA INVENCIÓN SE REFIERE A LOS PRODUCTOS NUEVOS DE FORMULA (I): EN LA QUE: N = 0,1 Ó 2; X REPRESENTA H, HAL O ALK; R REPRESENTA H, NH2, NHALK, N(ALK)2; RA REPRESENTA H; HAL; -O-CICLOALQUILO; -O-ALQUILO, -O-ARILO; -O-HETEROARILO; -NRD(CICLOALQUILO); -NRD(ALQUILO); -NRD(ARILO); -NRD(HETEROARILO); ALQUILO; CICLOALQUILO; HETEROCICLOALQUILO; ARILO O HETEROARILO; TODOS OPCIONALMENTE SUSTITUIDOS; RB REPRESENTA H, RC, -COORC,-CO-RC O -CO-NRCRD; CON RC REPRESENTANDO ALQUILO, CICLOALQUILO, HETEROCICLOALQUILO, ARILO Y HETEROARILO, TODOS OPCIONALMENTE SUSTITUIDOS; RD REPRESENTA H, ALK O CICLOALQUILO; ESTANDO ESTOS PRODUCTOS EN TODAS LAS FORMAS ISÓMERAS Y LAS SALES, COMO MEDICAMENTOS PRINCIPALMENTE COMO INHIBIDORES DE MET
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0804086A FR2933982A1 (fr) | 2008-07-18 | 2008-07-18 | Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2011003811A true SV2011003811A (es) | 2011-04-29 |
Family
ID=40352183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2011003811A SV2011003811A (es) | 2008-07-18 | 2011-01-17 | Nuevos derivados de imidazo[1,2-a] pirimidina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met |
Country Status (26)
Country | Link |
---|---|
US (1) | US20110263593A1 (es) |
EP (1) | EP2318414A2 (es) |
JP (1) | JP2011528339A (es) |
KR (1) | KR20110043680A (es) |
CN (1) | CN102159577A (es) |
AR (1) | AR072820A1 (es) |
AU (1) | AU2009272518A1 (es) |
BR (1) | BRPI0915920A2 (es) |
CA (1) | CA2730964A1 (es) |
CL (1) | CL2011000118A1 (es) |
CO (1) | CO6341634A2 (es) |
CR (1) | CR20110031A (es) |
DO (1) | DOP2011000019A (es) |
EA (1) | EA201170224A1 (es) |
EC (1) | ECSP11010765A (es) |
FR (1) | FR2933982A1 (es) |
IL (1) | IL210708A0 (es) |
MA (1) | MA32564B1 (es) |
MX (1) | MX2011000670A (es) |
NI (1) | NI201100020A (es) |
PE (1) | PE20110584A1 (es) |
SV (1) | SV2011003811A (es) |
TW (1) | TW201011025A (es) |
UY (1) | UY31998A (es) |
WO (1) | WO2010007318A2 (es) |
ZA (1) | ZA201100428B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
WO2011121223A1 (fr) | 2010-03-30 | 2011-10-06 | Sanofi-Aventis | Derives de 6-(alkyl- ou cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles: preparation, application comme medicaments et utilisation comme inhibiteurs de met |
CN102796103A (zh) * | 2011-05-23 | 2012-11-28 | 南京英派药业有限公司 | 6-(芳基甲酰)咪唑并[1,2-a]嘧啶和6-(芳基甲酰)[1,2,4]***并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用 |
WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
US11673891B2 (en) | 2017-11-14 | 2023-06-13 | Dana-Farber Cancer Institute, Inc. | Imidazopyrimidine compounds and uses thereof |
CN111587114A (zh) | 2017-11-14 | 2020-08-25 | 儿童医学中心公司 | 用于调节人免疫应答的咪唑并嘧啶的用途 |
KR20210142154A (ko) | 2019-03-21 | 2021-11-24 | 옹쎄오 | 암 치료를 위한 키나제 억제제와 조합된 dbait 분자 |
CA3159348A1 (en) | 2019-11-08 | 2021-05-14 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2785157A (en) * | 1952-11-05 | 1957-03-12 | Eastman Kodak Co | Benzothiazoleazoaniline compounds |
WO1999001454A1 (en) * | 1997-07-03 | 1999-01-14 | Du Pont Pharmaceuticals Company | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
NZ510013A (en) * | 1998-09-11 | 2003-11-28 | Warner Lambert Co | Dihydropyrones with selected heterocycles replacing the phenyls bearing polar substituents used as HIV protease inhibitors |
HUP0300359A2 (hu) * | 2000-02-07 | 2003-06-28 | Abbott Gmbh & Co. Kg. | 2-Benzotiazolil-karbamid-származékok és protein kináz inhibitorként történő felhasználásuk és ezeket tartalmazó gyógyszerkészítmények |
AU2005207946A1 (en) * | 2004-01-23 | 2005-08-11 | Amgen Inc. | Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer |
WO2006038001A1 (en) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Aminopyrimidine derivatives as jnk inhibitors |
EP1674466A1 (en) * | 2004-12-27 | 2006-06-28 | 4Sc Ag | 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
MY188338A (en) * | 2006-11-22 | 2021-11-30 | Incyte Holdings Corp | Imidazotriazines and imidazopyrimidines as kinase inhibitors |
-
2008
- 2008-07-18 FR FR0804086A patent/FR2933982A1/fr not_active Withdrawn
-
2009
- 2009-07-16 EP EP09737062A patent/EP2318414A2/fr not_active Withdrawn
- 2009-07-16 WO PCT/FR2009/051408 patent/WO2010007318A2/fr active Application Filing
- 2009-07-16 KR KR1020117003698A patent/KR20110043680A/ko not_active Application Discontinuation
- 2009-07-16 EA EA201170224A patent/EA201170224A1/ru unknown
- 2009-07-16 MX MX2011000670A patent/MX2011000670A/es not_active Application Discontinuation
- 2009-07-16 JP JP2011517980A patent/JP2011528339A/ja not_active Withdrawn
- 2009-07-16 PE PE2011000049A patent/PE20110584A1/es not_active Application Discontinuation
- 2009-07-16 BR BRPI0915920-7A patent/BRPI0915920A2/pt not_active IP Right Cessation
- 2009-07-16 CN CN200980136540XA patent/CN102159577A/zh active Pending
- 2009-07-16 AU AU2009272518A patent/AU2009272518A1/en not_active Abandoned
- 2009-07-16 TW TW098124145A patent/TW201011025A/zh unknown
- 2009-07-16 CA CA2730964A patent/CA2730964A1/fr not_active Abandoned
- 2009-07-17 AR ARP090102728A patent/AR072820A1/es unknown
- 2009-07-17 UY UY0001031998A patent/UY31998A/es not_active Application Discontinuation
-
2011
- 2011-01-17 NI NI201100020A patent/NI201100020A/es unknown
- 2011-01-17 US US13/007,830 patent/US20110263593A1/en not_active Abandoned
- 2011-01-17 ZA ZA2011/00428A patent/ZA201100428B/en unknown
- 2011-01-17 IL IL210708A patent/IL210708A0/en unknown
- 2011-01-17 SV SV2011003811A patent/SV2011003811A/es unknown
- 2011-01-17 DO DO2011000019A patent/DOP2011000019A/es unknown
- 2011-01-17 CR CR20110031A patent/CR20110031A/es not_active Application Discontinuation
- 2011-01-18 CO CO11004605A patent/CO6341634A2/es not_active Application Discontinuation
- 2011-01-18 EC EC2011010765A patent/ECSP11010765A/es unknown
- 2011-01-18 CL CL2011000118A patent/CL2011000118A1/es unknown
- 2011-02-15 MA MA33618A patent/MA32564B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0915920A2 (pt) | 2018-07-10 |
AU2009272518A1 (en) | 2010-01-21 |
WO2010007318A2 (fr) | 2010-01-21 |
WO2010007318A3 (fr) | 2010-04-08 |
EP2318414A2 (fr) | 2011-05-11 |
PE20110584A1 (es) | 2011-09-10 |
ECSP11010765A (es) | 2011-02-28 |
CA2730964A1 (fr) | 2010-01-21 |
MA32564B1 (fr) | 2011-08-01 |
JP2011528339A (ja) | 2011-11-17 |
CR20110031A (es) | 2011-03-14 |
US20110263593A1 (en) | 2011-10-27 |
MX2011000670A (es) | 2011-04-11 |
DOP2011000019A (es) | 2011-02-15 |
UY31998A (es) | 2010-02-26 |
ZA201100428B (en) | 2012-03-28 |
NI201100020A (es) | 2011-07-21 |
CL2011000118A1 (es) | 2011-07-15 |
CO6341634A2 (es) | 2011-11-21 |
TW201011025A (en) | 2010-03-16 |
KR20110043680A (ko) | 2011-04-27 |
EA201170224A1 (ru) | 2011-08-30 |
FR2933982A1 (fr) | 2010-01-22 |
CN102159577A (zh) | 2011-08-17 |
IL210708A0 (en) | 2011-03-31 |
AR072820A1 (es) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2011003811A (es) | Nuevos derivados de imidazo[1,2-a] pirimidina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
CO6331467A2 (es) | Nuevos derivados de imidazo(1,2-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
CO6331463A2 (es) | Nuevos derivados de triazolo(4,3-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
UY32649A (es) | "sales de 4-(dimetilamino)butil 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato" | |
UY31277A1 (es) | Nuevos derivados de 6-triazolopiridacina -sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmacéuticas y nueva utilizacion principalmente como inhibidores de met | |
DOP2012000310A (es) | Morfolinopirimidinas y su uso en terapia | |
ECSP055853A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
UY32156A (es) | Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones. | |
PA8798901A1 (es) | Nuevos derivados de 6- aril/heteroalquiloxi benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de cmet" | |
UY31639A1 (es) | Derivados de amida espirocíclica de fórmula i, sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolas, procesos de preparación y aplicaciones | |
UY31922A (es) | Compuestos | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
CU20120002A7 (es) | DERIVADOS DE 1-(5,6-DIHIDROIMIDAZO(1,2-a)PIRAZIN-7(8H)-IL )ETANONA | |
CR9469A (es) | Derivados de urea, metodos para su fabricacion y usos para los mismos | |
UY32753A (es) | NUEVOS DERIVADOS DE 2,3-DIHIDRO-1H-IMIDAZO{1,2-a}PIRIMIDIN-5-ONA, SU PREPARACIÓN Y SU UTILIZACIÓN EN FARMACÉUTICA | |
UY28835A1 (es) | Nuevos derivados de la pirrolo (2, 3-b) piridina, su preparación y su utilización farmcéutica como inhibidores de cinasas. | |
ECSP088441A (es) | Derivados de pirazolo [4,3-d]pirimidin-5-il usados como inhibidores de pde5 | |
UY32422A (es) | Derivados de 6-(6-sustituido-triazlopiridacina-sulfanil) 5-fluoro-benzotiazololes y 5-fluoro-bencimidazoles : preparacion, aplicacion como medicamentos y utilizacion como inhibidores de met | |
UY33873A (es) | Compuestos de pirazol como antagonistas de crth2 | |
UY32420A (es) | Derivados de 6-(6-sustituido-triazolopiridazina-sulfanil)benzotiazoles y bencimidazoles : preparacion, aplicacion como medicamentos y utilizacion como inhibidores de met | |
DOP2010000257A (es) | Compuesto ( r) -n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico | |
HN2010000295A (es) | Nuevos derivados de 6- triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion , su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met | |
UY32419A (es) | Derivados de 6-(6-o-cicloalquil o de 6-nh-cicloalquil-triazolopiridazina-sulfanil) benzotiazoles y bencimidazoles: preparacion, aplicacion como medicamentos y utilizacion como inhibidores de la met |